And that's just the Blood Cancer market.
The challenges when trying to estimate TAM (Total Addressable Market)...
- IMU has multiple cancer products in research (not just blood cancers).
- Blood cancers are 6% of ALL cancer cases - SIX PERCENT!!!
- Addressable market = [Total Cases] X [Revenue Per case] X percentage that will/who are able to seek treatment.
The indeterminate here is PRICE.
What price do you charge for a clearly superior treatment?
Write your own cheque.
Welcome to marketing.
Why IMU is a multi multi bagger, page-18386
-
- There are more pages in this discussion • 7,677 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |